The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

Kanhailal AC, Lucassen MJJ, Schutte T, Zwart W, Huitema ADR, Steeghs N

DOI: 10.1007/s00280-026-04924-7
Published: 2026 Jul 6
Container: Cancer chemotherapy and pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00280-026-04924-7,
  title = {The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.},
  author = {Kanhailal AC and Lucassen MJJ and Schutte T and Zwart W and Huitema ADR and Steeghs N},
  year = {2026},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-026-04924-7},
  url = {https://doi.org/10.1007/s00280-026-04924-7}
}

RIS

TY  - JOUR
TI  - The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.
AU  - Kanhailal AC
AU  - Lucassen MJJ
AU  - Schutte T
AU  - Zwart W
AU  - Huitema ADR
AU  - Steeghs N
PY  - 2026
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-026-04924-7
UR  - https://doi.org/10.1007/s00280-026-04924-7
ER  -

APA

AC, K., MJJ, L., T, S., W, Z., ADR, H., & N, S. (2026). The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-026-04924-7

Source records

pubmed · retrieved 2026-09-25T12:23:21.569Z